IMMUNOVANT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.44 USD | -0.18% |
|
-4.09% | -34.87% |
| 20/04 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
| 20/04 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
Chart calendar Immunovant, Inc.
dea399d58f54e5e4af29.04BKHGEbaBkIgSZpg-SGYGIWvlu3loAdZMqOHCkoE70.lOMpbxJRW1Vmy0Eg2qzPTTtw7A75pNd1Ib3FUmVCZMem83tmOF8ZWjjWHg~573139ea708174f966ce8e580b92682f
Upcoming events on Immunovant, Inc.
Past events on Immunovant, Inc.
| 12/02/2024 05:30 pm | Q3 2024 Earnings Release |
| 09/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 30/11/2023 10:00 pm | Piper Sandler Healthcare Conference |
| 29/11/2023 03:35 am | Evercore ISI HealthCONx Conference |
| 28/11/2023 06:30 pm | IMVT-1402 Phase 1 Results Call |
| 16/11/2023 12:20 am | Stifel Healthcare Conference |
| 09/11/2023 05:30 pm | Q2 2024 Earnings Release |
| 26/09/2023 05:30 pm | IMVT-1402 Phase 1 Results Call |
| 22/08/2023 02:00 am | Annual General Meeting |
| 10/08/2023 04:30 pm | Q1 2024 Earnings Release |
| 22/05/2023 04:30 pm | Q4 2023 Earnings Release |
| 03/02/2023 05:30 pm | Q3 2023 Earnings Release |
| 15/11/2022 02:25 am | Guggenheim Immunology and Neurology Day |
| 04/11/2022 04:30 pm | Interim 2023 Earnings Release |
| 28/09/2022 08:45 pm | Roivant Investor Day |
| 15/09/2022 01:30 am | H.C. Wainwright Global Investment Conference |
| 07/09/2022 05:30 pm | Business Update Call |
| 18/08/2022 12:00 am | Annual General Meeting |
| 05/08/2022 04:30 pm | Q1 2023 Earnings Release |
| 08/06/2022 05:30 pm | FY 2022 Earnings Call |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -108 -112 3.52% | -156 -135 -15.3% | -218 -186 -17.49% | -259 |
|
EBIT Million USD | Released Forecast Spread | -66,1 -77,7 14.97% | -108 -113 3.94% | -156 -151 -3.48% | -218 -201 -8.6% | -266 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -66,3 -65,5 -1.19% | -108 -112 4.01% | -157 -157 -0.06% | -211 -207 -1.82% | -252 |
|
Net income Million USD | Released Forecast Spread | -66,4 -65,6 -1.24% | -107 -112 4.17% | -157 -156 -0.33% | -211 -205 -2.85% | -250 |
|
EPS USD | Released Forecast Spread | -1,54 -1,15 -33.91% | -1,22 -1,29 5.34% | -1,43 -1,39 -2.75% | -1,71 -1,65 -3.72% | -1,79 |
| Announcement Date | 29/06/20 | 01/06/21 | 08/06/22 | 22/05/23 | - |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -47,2 -28,2 -67.54% | -40,3 -30,0 -34.53% | -49,6 -33,8 -46.65% | -64,0 -36,5 -75.47% | -64,2 -40,9 -57.15% | -78,4 -44,0 -78.24% | -61,7 -45,4 -35.95% | -61,4 -60,5 -1.55% | -63,5 | |||||
|
EBIT Million USD | Released Forecast Spread | -41,3 -36,8 -12.1% | -47,2 -42,6 -10.95% | -40,4 -46,2 12.64% | -49,6 -45,6 -8.81% | -64,0 -49,3 -29.97% | -64,3 -54,5 -17.84% | -78,5 -60,2 -30.37% | -61,8 -64,8 4.56% | -61,6 -64,1 4.02% | -64,7 | -68,8 | -73,1 | -75,8 | -78,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,4 -36,0 -14.96% | -47,2 -44,8 -5.28% | -40,0 -46,1 13.15% | -47,7 -47,1 -1.11% | -62,8 -50,0 -25.62% | -60,4 -57,8 -4.59% | -73,9 -59,8 -23.73% | -58,2 -65,9 11.64% | -51,5 -65,4 21.2% | -65,2 | -66,6 | -68,4 | -70,4 | -76,4 |
|
Net income Million USD | Released Forecast Spread | -41,4 -36,0 -14.96% | -47,2 -44,6 -5.65% | -40,4 -46,2 12.63% | -47,9 -46,3 -3.42% | -63,2 -50,8 -24.41% | -59,4 -57,8 -2.74% | -73,9 -57,3 -29.11% | -58,7 -62,9 6.72% | -51,4 -62,4 17.66% | -63,0 | -65,3 | -67,6 | -70,3 | -75,8 |
|
EPS USD | Released Forecast Spread | -0,36 -0,32 -14.03% | -0,41 -0,36 -13.54% | -0,35 -0,40 11.55% | -0,41 -0,39 -6.41% | -0,49 -0,40 -23.02% | -0,46 -0,45 -1.36% | -0,57 -0,44 -28.48% | -0,45 -0,48 5.35% | -0,36 -0,43 16.71% | -0,44 | -0,45 | -0,46 | -0,48 | -0,51 |
| Announcement Date | 04/02/22 | 08/06/22 | 05/08/22 | 04/11/22 | 03/02/23 | 22/05/23 | 10/08/23 | 09/11/23 | 12/02/24 | - | - | - | - | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Immunovant, Inc.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 01:31 am | MORPHOSYS AG: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 28/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMVT Stock
- Calendar Immunovant, Inc.
